Effects of CYP2D6 allelic variants on therapy with tamsulosin in patients with benign prostatic hyperplasia.

Skokhrukh P Abdullaev,Maksim N Shatokhin,Svetlana N Tuchkova,Sherzod P Abdullaev,Oleg V Teodorovich,Oleg B Loran,Dmitry A Sychev

Drug metabolism and personalized therapy（2023）

引用 0|浏览2

暂无评分

摘要

The results of the study show that in patients with moderate LUTS associated with BPH who are «intermediate» metabolizers by CYP2D6, there is a better therapeutic effect of tamsulosin.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要